BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30305465)

  • 1. Time-action profiles of insulin degludec in healthy dogs and its effects on glycemic control in diabetic dogs.
    Oda H; Mori A; Ishii S; Shono S; Onozawa E; Sako T
    J Vet Med Sci; 2018 Nov; 80(11):1720-1723. PubMed ID: 30305465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-action profiles of insulin detemir in normal and diabetic dogs.
    Sako T; Mori A; Lee P; Oda H; Saeki K; Miki Y; Kurishima M; Mimura K; Nozawa S; Mizutani H; Makino Y; Ishioka K; Arai T
    Res Vet Sci; 2011 Jun; 90(3):396-403. PubMed ID: 20708207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the action of Neutral Protamine Hagedorn human analogue insulin in dogs with naturally occurring diabetes mellitus.
    Palm CA; Boston RC; Refsal KR; Hess RS
    J Vet Intern Med; 2009; 23(1):50-5. PubMed ID: 19175720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blood glucose response to three prolonged duration insulins in canine diabetes mellitus.
    Church DB
    J Small Anim Pract; 1981 Jun; 22(6):301-10. PubMed ID: 7031365
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study.
    Fracassi F; Linari G; Del Baldo F; Di Cunzolo A; D'Angelo S; Malerba E; Carotenuto G; Bonfanti U; Corradini S
    Vet Rec; 2018 Sep; 183(8):262. PubMed ID: 30030413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of time-action profiles of insulin glargine and NPH insulin in normal and diabetic dogs.
    Mori A; Sako T; Lee P; Motoike T; Iwase K; Kanaya Y; Fukuta H; Mizutani H; Arai T
    Vet Res Commun; 2008 Oct; 32(7):563-73. PubMed ID: 18575956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day-to-day variability of porcine lente, insulin glargine 300 U/mL and insulin degludec in diabetic dogs.
    Miller M; Pires J; Crakes K; Greathouse R; Quach N; Gilor C
    J Vet Intern Med; 2021 Sep; 35(5):2131-2139. PubMed ID: 34241910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
    Maggiore AD; Nelson RW; Dennis J; Johnson E; Kass PH
    J Vet Intern Med; 2012; 26(1):109-15. PubMed ID: 22211582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges.
    King AB; Philis-Tsimikas A; Kilpatrick ES; Langbakke IH; Begtrup K; Vilsbøll T
    Diabetes Technol Ther; 2017 Apr; 19(4):255-264. PubMed ID: 28282219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment with lispro and neutral protamine Hagedorn insulins on serum fructosamine and postprandial blood glucose concentrations in dogs with clinically well-controlled diabetes mellitus and postprandial hyperglycemia.
    Bertalan AV; Drobatz KJ; Hess RS
    Am J Vet Res; 2020 Feb; 81(2):153-158. PubMed ID: 31985281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term field study of lispro and neutral protamine Hagedorn insulins treatment in dogs with diabetes mellitus.
    Kuzi S; Mazaki-Tovi M; Hershkovitz S; Yas E; Hess RS
    Vet Med Sci; 2023 Mar; 9(2):704-711. PubMed ID: 36795089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin degludec versus insulin glargine on glycemic control and daily fasting blood glucose variability in insulin-naïve Japanese patients with type 2 diabetes: I'D GOT trial.
    Aso Y; Suzuki K; Chiba Y; Sato M; Fujita N; Takada Y; Murano S; Kuroda H
    Diabetes Res Clin Pract; 2017 Aug; 130():237-243. PubMed ID: 28651211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region.
    Nosek L; Coester HV; Roepstorff C; Thomsen HF; Kristensen NR; Haahr H; Heise T
    Clin Drug Investig; 2014 Sep; 34(9):673-9. PubMed ID: 25124362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of glycemic variability in Japanese patients with type 1 diabetes receiving insulin degludec versus insulin detemir using continuous glucose monitoring: a randomized, cross-over, pilot study.
    Takahashi H; Nishimura R; Onda Y; Ando K; Tsujino D; Utsunomiya K
    Expert Opin Pharmacother; 2017 Mar; 18(4):335-342. PubMed ID: 28234565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine.
    Heise T; Hövelmann U; Nosek L; Hermanski L; Bøttcher SG; Haahr H
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1193-201. PubMed ID: 26086190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).
    Buse JB; Vilsbøll T; Thurman J; Blevins TC; Langbakke IH; Bøttcher SG; Rodbard HW;
    Diabetes Care; 2014 Nov; 37(11):2926-33. PubMed ID: 25114296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials.
    Russell-Jones D; Gall MA; Niemeyer M; Diamant M; Del Prato S
    Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):898-905. PubMed ID: 26232910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Daytime flexible application of Insulin degludec in patients with type 1 diabetes or type 2 diabetes].
    Lüdemann J; Milek K; Wilhelm B; Segner A; Jaeckel E
    MMW Fortschr Med; 2014 Oct; 156 Suppl 3():89-97. PubMed ID: 25417447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
    Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replacing Insulin Glargine with Neutral Protamine Hagedorn (NPH) Insulin in a Subpopulation of Study Subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on Blood Glucose Levels, Hypoglycemia and Patient Satisfaction.
    Berard L; Cameron B; Woo V; Stewart J
    Can J Diabetes; 2015 Aug; 39(4):296-301. PubMed ID: 25819531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.